Indian Leaders Begin Unique Collaboration On Molnupiravir

Including Cipla, Dr Reddy’s, Emcure, Sun Pharma and Torrent

Major Indian pharmaceutical companies including Cipla, Dr Reddy’s, Emcure, Sun and Torrent have entered into a first-of-its-kind collaboration to jointly sponsor, supervise and monitor the clinical trial of the investigational oral anti-viral drug molnupiravir to fight against COVID-19 in India. 

India COVID
The five companies will jointly sponsor, supervise and monitor the clinical trial for molnupiravir • Source: Alamy

More from Products

More from Generics Bulletin